Larvol Delta - Brepocitinib-Achieves-Rapid-and-Sustained-Control-of-Cutaneous-Disease-Activity-Itch-and-SkinRelated-Quality-of-Life-in-Dermatomyositis-Results-From-the-Phase-3-VALOR-Trial

Lisraya (brepocitinib) - Priovant Therap

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1898479&mode=presInfo

Ruth Ann Vleugels, MD,MPH,MBA

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next